3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Neoplasms
15
Breast Neoplasms
13
Stomach Neoplasms
12
Prostatic Neoplasms
12
Colorectal Neoplasms
11
Pancreatic Neoplasms
9
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma, Hepatocellular
7
Endometrial Neoplasms
5
Colonic Neoplasms
4
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Polycystic Ovary Syndrome
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Skin Neoplasms
2
Salivary Gland Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Peritoneal Neoplasms
2
Papillomavirus Infections
2
Obesity
2
Multiple Myeloma
2
Interventions
Surveys and Questionnaires
5
Psychiatric Rehabilitation
4
ziprasidone
1
Zolpidem
1
Weights and Measures
1
Warfarin
1
Waiting Lists
1
Vecuronium Bromide
1
Vancomycin
1
Transurethral Resection of Prostate
1
Tranexamic Acid
1
Tobramycin
1
Thyroidectomy
1
Therapeutics
1
Spironolactone
1
Single Person
1
Sevelamer
1
Rocuronium
1
Restraint, Physical
1
Radiosurgery
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Observation
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Anxiety Disorders
×
Observation
×
Clear all
NCT03818230
2020-03-24
EPIC
University of Manchester
Completed
64 enrolled